Nozomi - Digital Health Product Studio

Nozomi is a digital health product studio founded in 2020 (originally as Remdev) that focuses exclusively on building patient-centered healthcare applications. The Poland-based company employs over 30 professionals and has completed more than 50 digital health projects for startups and healthcare providers. The studio pivoted to healthcare specialization in 2021 and rebranded to Nozomi in 2022.

The company's core competency centers on creating digital health products that emphasize patient engagement and behavioral change. Their service offerings include three main tracks: end-to-end Patient Engagement Build consulting, prebuilt AI Engagement Agents deployable via SDK, and compliance-focused development. They work across multiple healthcare product categories including digital therapeutics, remote patient monitoring platforms, prevention companions, telehealth solutions, and Software as a Medical Device (SaMD).

Nozomi positions itself as a partner rather than a vendor, integrating with client teams from discovery through execution. The studio emphasizes empathy-led design combined with behavioral science principles, and maintains a stated focus on creating products that reduce patient stress while improving engagement and adherence outcomes.

Choose Nozomi if you're building a patient-facing digital health product where engagement and behavioral change are critical success factors. The studio's healthcare-exclusive focus and behavioral science methodology make them particularly suited for digital therapeutics, chronic disease management apps, or prevention-focused solutions that require ongoing user motivation.

Expect a collaborative partnership approach with embedded team integration. The studio's prebuilt AI engagement components can accelerate time-to-market for organizations looking to add conversational features without building from scratch. Their pricing model typically begins with fixed-price discovery followed by milestone-based or time-and-materials execution.

Nozomi operates exclusively in the healthcare sector, having transitioned from general startup work to 100% healthcare focus in 2021. The studio specializes in patient-facing digital health applications across multiple therapeutic areas including dementia care, dermatology, obesity management, and behavioral health. Their expertise spans regulatory requirements for digital therapeutics, Software as a Medical Device development, and HIPAA-compliant architecture.

The company demonstrates specific healthcare domain knowledge through their work on remote patient monitoring platforms, care companion applications, and prevention-focused behavioral change tools. Their approach integrates healthcare-specific considerations like clinical workflow integration, EHR connectivity, and evidence-based therapeutic protocols into product development.

Digital health startups in seed through Series B stages building patient-facing applications, particularly those in behavioral health, chronic disease management, or preventive care verticals. Healthcare providers or health systems looking to develop custom digital therapeutics or remote monitoring solutions with strong patient engagement requirements.